Using heart rate data from wrist worn activity trackers to define thresholds for moderate to vigorous physical activity in children and young people with cystic fibrosis

Heart Failure

Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study

ESC Heart Fail

Kocabas U, Ergin I, Yavuz V, Altın C, Kaplan M, Yılmaz Öztekin GM, Doğduş M, Murat S, Murat B, Kıvrak T, Karabulut D, Kaya E, Özdemir İH, Yıldız C, Salkın FÖ, Özçalık E, Polatkan ŞG, Çakan F, Şen T, Karabulut U, Çakal S, Oflar E, Sinan ÜY, Yenerçağ M, Türk UÖ

doi: 10.1002/ehf2.15049

Heart, Artery and Coronary Diseases

Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial

Circ Cardiovasc Qual Outcomes

Slater J, Maron DJ, Jones PG, Bangalore S, Reynolds HR, Fu Z, Stone GW, Kirby R, Hochman JS, Spertus JA, ISCHEMIA Research Group

doi: 10.1161/CIRCOUTCOMES.124.010849

Heart, Artery and Coronary Diseases

Moderate Aortic Valve Stenosis Is Associated With Increased Mortality Rate and Lifetime Loss: Systematic Review and Meta-Analysis of Reconstructed Time-to-Event Data of 409 680 Patients

J Am Heart Assoc

Jacquemyn X, Strom JB, Strange G, Playford D, Stewart S, Kutty S, Bhatt DL, Bleiziffer S, Grubb KJ, Pellikka PA, Clavel MA, Pibarot P, Mentias A, Serna-Gallegos D, Sá MP, Sultan I

doi: 10.1161/JAHA.123.033872

RECOMMENDED

Hypertension

The Diagnostic Accuracy of Using Borderline High Office Blood Pressure Thresholds to Diagnose Masked Hypertension According to the 2017 American College of Cardiology / American Heart Association Blood Pressure Guideline

★ 2 Recommended by Prof. Dr Isabella Sudano, Faculty Member

Am J Hypertens

Walsh S, Choi E, Fang C, Narita K, Cepeda M, Frangaj B, Kim S, Mercado Y, Nesheim-Case R, Ramirez UA, Barrett M, Schwartz JE, Shimbo D

doi: 10.1093/ajh/hpaf017

Heart Failure

Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry

Eur J Heart Fail

Lund LH, Crespo-Leiro MG, Laroche C, Zaliaduonyte D, Saad AM, Fonseca C, Čelutkienė J, Zdravkovic M, Bielecka-Dabrowa AM, Agostoni P, Xuereb RG, Neronova KV, Lelonek M, Cavusoglu Y, Gellen B, Abdelhamid M, Hammoudi N, Anker SD, Chioncel O, Filippatos G, Lainscak M, McDonagh TA, Mebazaa A, Piepoli M, Ruschitzka F, Seferović PM, Savarese G, Metra M, Rosano GMC, Maggioni AP, ESC EORP HF III National Leaders and Investigators

doi: 10.1002/ejhf.3445

Heart Failure

Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry

Eur J Heart Fail

Ferrari A, Stolfo D, Uijl A, Orsini N, Benson L, Sinagra G, Mol P, de Vries ST, Dahlström U, Rosano G, Lund LH, Savarese G

doi: 10.1002/ejhf.3272

Heart Failure

Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document

Eur J Heart Fail

Bozkurt B, Mullens W, Leclercq C, Russo AM, Savarese G, Böhm M, Hill L, Kinugawa K, Sato N, Abraham WT, Bayes-Genis A, Mebazaa A, Rosano GMC, Zieroth S, Linde C, Butler J

doi: 10.1002/ejhf.3641

RECOMMENDED

Heart Failure

Association of sex with in-hospital management and outcomes of patients with heart failure: data from the REAL-HF registry: The impact of sex in patients hospitalized for heart failure

★ 3 Recommended by Prof. Dr Isabella Sudano, Faculty Member

Am Heart J

Sanna GD, Erre GL, Cameli M, Guerra F, Pastore MC, Marini A, Campora A, Gironella P, Costamagna M, Mandoli GE, Casiraghi M, Scuteri A, Lisi M, Casu G, Deidda M, Dessalvi CC, REAL-HF investigators

doi: 10.1016/j.ahj.2024.08.018

Heart Failure

Guideline-directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort

ESC Heart Fail

Berry NC, Sheu YS, Chesbrough K, Bishop RC, Vupputuri S

doi: 10.1002/ehf2.15193

Related content

Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study

Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial

Moderate Aortic Valve Stenosis Is Associated With Increased Mortality Rate and Lifetime Loss: Systematic Review and Meta-Analysis of Reconstructed Time-to-Event Data of 409 680 Patients

The Diagnostic Accuracy of Using Borderline High Office Blood Pressure Thresholds to Diagnose Masked Hypertension According to the 2017 American College of Cardiology / American Heart Association Blood Pressure Guideline

Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry

Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry

Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document

Association of sex with in-hospital management and outcomes of patients with heart failure: data from the REAL-HF registry: The impact of sex in patients hospitalized for heart failure

Guideline-directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort